OrthogetS.A.
Research and experimental development in natural sciences and engineering
Overview
Orthoget is a company that develops bio-tech solutions for orthopedics, specifically addressing lower limb asymmetry. They create innovative orthopedic products supported by integrated digital monitoring systems, including a dynamic intramedullary nail for clinical trials. Their services also involve conducting clinical research on limb lengthening treatments at their partner clinic, Trigon Orthopedia in Warsaw.
Financials
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2017-07-01. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
10 public aid cases recorded, with a total value of $1,863,194.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 26, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Agencja Rozwoju Aglomeracji Wrocławskiej S.A. | |
| Sep 15, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Agencja Rozwoju Aglomeracji Wrocławskiej S.A. | |
| Apr 23, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Agencja Rozwoju Aglomeracji Wrocławskiej S.A. |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-05-01 | Hybrydowy gwóźdź śródszpikowy z napędem magneto-mechanicznym przeznaczonym do wydłużania kości długich człowieka | $1.5M$1,544,566 | Program Operacyjny Inteligentny Rozwój |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
The following persons are authorised to make declarations of will on behalf of the company: 1. in the case of a one-person management board: each member of the management board independently; 2. in the case of a multi-member management board, making declarations on behalf of the company requires the joint action of two members of the management board or of one member of the management board jointly with a commercial proxy.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Sidlysp. z o.o. | $4,977,649.42 | sidly.eu | ||
| Read-GeneS.A. | $2,163,474.84 | read-gene.com | ||
| BiokineticaS.A. | $1,292,838.89 | biokinetica.com | ||
| Scope FluidicsS.A. | $1,264,188.85 | scopefluidics.com | ||
| Gispro Technologiessp. z o.o. | $1,072,782.38 | gispro.pl | ||
| Bioresearch Groupsp. z o.o. | $776,186.19 | bioresearch.pl | ||
| MedisensonicS.A. | $362,572.63 | medisensonic.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Awtmsp. z o.o. | $123,062.45 | awtm.pl | ||
| Opessp. z o.o. | $56,182.11 | opes.com.pl |
FAQ
Last updated: 2026-10-13